MEDP Limited Partnership Medpace sells $125.4M worth of shares
Jan 01, 2026, 5:35 AM
0.00%
What does MEDP do
Medpace Holdings, headquartered in Cincinnati, Ohio, offers outsourced clinical development services to the biotechnology and pharmaceutical industries, employing 5,800 staff since its IPO in 2016. The firm specializes in full-service Phase I-IV clinical trial support across North America, Europe, and Asia.
Limited Partnership Medpace sold 3,000,000 shares of MEDP on 14 June at $41.80 per share, worth a total of $125.4M. They now own 10,399,997 MEDP shares, or a 22% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.